维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="POLLINA L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of PTEN expression in colorectal cancer (CRC) metastases (mets) and in primary tumors as predictors of activity of cetuximab plus irinotecan treatment 显示文摘	Loupakis F Pollina L Stasi I	2008	J Clin Oncol2008，，：	1
2	PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for pa- tients with metastatic colorectal cancer显示文摘	Loupakis F Pollina L Stasi I	2009	J Clin Oncol2009，27，16：	1
3	PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer显示文摘	LOUPAKIS F POLLINA L STASI I	2009	J Clin Oncol2009，27，16：	1
4	Evaluation of PTEN expression in colorectal cancer (CRC) metastases (mets) and in primary tumors as predictors of activity of cetuximab plus irinotecan treatment 显示文摘	Loupakis F Pollina L Stasi I et at	2008	J Clin Oncol2008，26，：	1
5	Evaluation of PTEN expression in colorectal cancer (CRC) metastases (mets) and in primary tumors as prediction of cetuximab plus irinotecan treatment 显示文摘	Loupakis F Pollina L Stasi I	2008	J Clin Oncol2008，，：	1
6	Life-span attachment:relations between attachment and socio-emotional functioning in adult women显示文摘	Barnas MV Pollina L Cummings EM		0，，：	1
7	Long - term outcome of initially unresectable metastatic colorectal cancer patients treated with 5 - fluorouracil/leucovofin, oxaliplatin, and irinotecan ( FOLFOXIRI ) followed by radical surgery of metastases显示文摘	Masi G Loupakis F Pollina L	2009	Ann Surg2009，249，3：	1
8	Evaluation of PTEN expression in colorectal cancer (CRC) metastases (mets) and in primary tumors as predictors of activity of cetuximab plus irinotecan treatment显示文摘	Loupakis F Pollina L Stasi I		0，，：	1
9	Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression显示文摘	Basolo F Pollina L Fontenini G	1997	Br J Cancer1997，75，4：	1
10	Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin,oxaliplatin,and irinotecan(FOLFOXIRI)followed by radical surgery of metastases显示文摘	MASI G LOUPAKIS F POLLINA L	2009	Ann Surg2009，249，3：	1
11	Evaluation of PTEN expression in colorectal cancer(CRC) metastases(mets) and in primary tumors as predictors of activity of cetuximab plus irinotecan treatment显示文摘	Loupakis F Pollina L Stasi I	2008	J Clin Oncol2008，26，：	1
12	PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer显示文摘	Loupakis F Pollina L Stasi Ⅰ		0，，16：	1
13	Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression显示文摘	BASOLO F POLLINA L FONTENINI G	1997	Br J Cancer1997，75，：	1
14	Eetopie expression of hone sialoprotein in human thyroid cancer显示文摘	BELLAHCENE A ALBERT V POLLINA L	1998	Thyroid1998，8，8：	1
15	Long-term outcome of initially unresectable metastatic colorectal cancer pa- tients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXI1LI) followed by radical sur- gery of metastases显示文摘	Masi G Loupakis F Pollina L	2009	Ann Surg2009，249，3：	1
16	Apoptosis and proliferation in thyroid crcinoma : correlation with bcl-2 and p53 protein expression显示文摘	Pollina L Fontenini G	1997	Br J Cancer1997，75，4：	1
17	PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plusirinotecan for patients with metastatic colorectal cancer显示文摘	LOUPAKIS F POLLINA L STASI I	2009	J Clin Oncol2009，27，16：	1
18	Evaluation of vascular infiltration in resected patients for pancreatic cancer: comparison among multidetector CT, intraoperative findings and histopathology显示文摘	Mazzeo S Cappelli C Caramella D Del Chiaro M Campani D Pollina L	2007	Abdom Imaging2007，32，：	1
19	Apoptosis and proliferation in thyroid carcinoma: correlation with Bc1-2 and P53 protein expression显示文摘	Basolo F Pollina L Fontanini G	1997	Br J Cancer1997，75，：	1
20	PTEN expression and KRAS mutations on primary tumors and metastases in the pre- diction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer 显示文摘	Loupakis F Pollina L Stasi I	2009	J Clin Oncol2009，27，16：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示